Today’s rising diagnostics costs and skills to do diagnostic tests limit access to early disease detection. We, Elyvia Biomedics, are addressing this challenge with a next-generation quantitative biomarker test platform for simple, fast, and convenient diagnostics. Our innovative molecular counter functions as a biomarker counter and a self-calibrating biosensor and integrates with machine learning for enhanced precision and lower cost. Compatible with smartphone cameras and existing readers, our solution enables cost-effective in vitro diagnostics at the point of care and at home. Our goal is to personalize diagnostics and treatment for a better life.

Our team is poised to achieve this. We are a group of seasoned, innovative entrepreneurs, biotech scientists, business developers, and clinicians with a proven track record of advancing the field of cutting-edge quantitative biophysical and biochemical methods and on the front line of personalized diagnostics and treatment.

Together with our partners, we are addressing the unmet need for rapid detection of some of the most complicated diseases to save lives and improve the quality of life.

Elyvia Biomedics

Org chart

Teams

Offices

Elyvia Biomedics

Org chart

Teams

Offices

Related companies